Adaptive Pharmacogenomics, LLC

Researchers have discovered a biomarker that could help in the treatment of patients with an aggressive type of lung cancer. Using a particular biomarker, researchers might better predict which patients with small cell lung cancer are resistant to existing drug therapies, and which ones could benefit from new therapies tailored to their specific needs.